Justin Holko | VP of IR |
Dr. Leonard Schleifer | Co-Founder, President & CEO |
Dr. George Yancopoulos | Co-Founder, President & Chief Scientific Officer |
Marion McCourt | SVP of Commercial |
Bob Landry | EVP of Finance & CFO |
Carter Gould | Barclays |
Chris Raymond | Piper Sandler |
Evan Seigerman | Crédit Suisse |
Yatin Suneja | Guggenheim Partners |
Yaron Werber | Cowen |
Geoffrey Porges | SVB Leerink |
Cory Kasimov | JPMorgan |
Robyn Karnauskas | Truist |
Alethia Young | Cantor |
Ronny Gal | Bernstein |
Biren Amin | Jefferies |
Ladies and gentlemen, thank you for standing by, and welcome to the Regeneron Pharmaceuticals Third Quarter 2020 Earnings Call. [Operator Instructions] I would now like to hand the conference over to your speaker Justin Holko. Please go ahead, sir.
Thank you, Deborah. Good morning, good afternoon and good evening to everyone listening around the globe.